Medable Sustainability Profile
Medable, officially known as Medable Inc., is a pioneering force in the digital health industry, headquartered in the United States. Founded in 2015, the company has rapidly established itself as a leader in decentralised clinical trials, transforming the way clinical research is conducted. With a focus on patient-centric solutions, Medable offers a comprehensive platform that streamlines trial processes, enhances patient engagement, and accelerates drug development. The company operates primarily in North America and Europe, providing innovative services that include remote patient monitoring, data collection, and trial management. Medable's unique approach leverages advanced technology to improve accessibility and efficiency in clinical trials, positioning it as a key player in the evolving landscape of healthcare. Notable achievements include partnerships with major pharmaceutical companies and recognition for its contributions to advancing clinical research methodologies.
DitchCarbon Score
How does Medable's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medable's score of 27 is lower than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medable's reported carbon emissions
Medable Inc., headquartered in the United States, has set ambitious climate commitments, particularly focusing on its greenhouse gas emissions. The company has established targets through the Science Based Targets initiative (SBTi) to maintain zero emissions for both Scope 1 and Scope 2 by 2030, using 2021 as the base year. This commitment reflects an absolute reduction target of 100% for these scopes, which encompass direct emissions from owned or controlled sources and indirect emissions from the generation of purchased electricity, respectively. While specific emissions data is not available, Medable's proactive stance includes plans to measure and reduce its Scope 3 emissions, which cover all other indirect emissions that occur in a company's value chain. This comprehensive approach aligns with the industry's best practices for climate action, aiming to contribute to the global goal of limiting temperature rise to 1.5°C. Medable's targets are particularly noteworthy as they were approved via a streamlined validation route tailored for small and medium-sized enterprises (SMEs), underscoring the company's commitment to sustainability within its operational framework.
How Carbon Intensive is Medable's Industry?
How Carbon Intensive is Medable's Location?
Medable's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Medable has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
